This highly recurrent deletion of USP28 that coincides with a downregulation of USP28 mRNA levels substantiates a possible role of USP28 loss in the dysregulation of signaling pathways that contribute to the pathobiology and disease course of del(11q) CLL. Here, USP28 is linked to B-cell chronic lymphocytic leukemia.